BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 13826523)

  • 1. The use of clinical dextran in patients with paroxysmal nocturnal hemoglobinuria.
    GARDNER FH; LAFORET MT
    J Lab Clin Med; 1960 Jun; 55():946-58. PubMed ID: 13826523
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical dextran for acute episodes in paroxysmal nocturnal haemoglobinuria.
    STRATTON F; WILKINSON JF; ISRAELS MC
    Lancet; 1958 Apr; 1(7025):831. PubMed ID: 13526288
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative management of patients with paroxysmal nocturnal hemoglobinuria.
    Braren V; Jenkins DE; Phythyon JM; Hartmann RC; Clark DA
    Surg Gynecol Obstet; 1981 Oct; 153(4):515-20. PubMed ID: 6169165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal nocturnal hemoglobinuria: the effect of dextran on hemolysis in vitro.
    CROSBY WH; BENJAMIN NR
    Acta Haematol; 1958; 19(4-5):193-8. PubMed ID: 13558967
    [No Abstract]   [Full Text] [Related]  

  • 5. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    THOMPSON RF
    SD J Med Pharm; 1963 Nov; 16():19-29. PubMed ID: 14081232
    [No Abstract]   [Full Text] [Related]  

  • 6. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CURRENT CONCEPTS OF CERTAIN PATHOPHYSIOLOGIC FEATURES.
    HARTMANN RC; JENKINS DE
    Blood; 1965 May; 25():850-65. PubMed ID: 14282055
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the therapy of paroxysmal nocturnal hemoglobinuria (Marchiafava-Micheli disease)].
    KRATZSCH KH
    Z Gesamte Inn Med; 1960 Dec; 15():1150-4. PubMed ID: 13754058
    [No Abstract]   [Full Text] [Related]  

  • 8. A splenectomized case of paroxysmal nocturnal hemoglobinuria (the marchiafava-nazari-micheli syndrome).
    ANDERSSON B
    Acta Med Scand; 1952 May; 143(3):197-206. PubMed ID: 14932825
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of paroxysmal nocturnal hemoglobinuria with ACTH.
    KALANT N; DONAT P
    Blood; 1952 Jun; 7(6):607-12. PubMed ID: 14925155
    [No Abstract]   [Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria treated with ACTH without benefit.
    HOFFMAN BJ; POWELL VE
    Blood; 1952 Oct; 7(10):1038-41. PubMed ID: 12977835
    [No Abstract]   [Full Text] [Related]  

  • 11. COEXISTENT PAROXYSMAL NOCTURNAL AND COLD HEMOGLOBINURIA PRECEDED BY APLASTIC ANEMIA: A CASE REPORT AND FAMILY STUDY.
    MENGEL CE; HYMAN BN; O'MALLEY BW; HOWELL DA
    Blood; 1964 Oct; 24():451-7. PubMed ID: 14220787
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria: report of four cases, with observations on treatment with 3, 3'-methylenebis (4-hydroxycoumarin) (dicumarol).
    PERKINS HA; BOULWARE JM; FEICHTMEIR TV; THAYER WW; SPAET TH
    Ann Intern Med; 1955 Dec; 43(6):1218-29. PubMed ID: 13269013
    [No Abstract]   [Full Text] [Related]  

  • 13. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    SIRCHIA G; FERRONE S; MERCURIALI F
    Blood; 1965 Apr; 25():502-10. PubMed ID: 14284339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prednisone therapy of Marchiafava-Micheli type of nocturnal paroxsymal hemoglobinuria].
    SCALFI L; NAPOLI V
    Minerva Med; 1955 Dec; 46(99):1733-5. PubMed ID: 13288095
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viewpoints on the management of paroxysmal nocturnal hemoglobinuria (PNH).
    Hartmann RC; Kolhouse JF
    Ser Haematol; 1972; 5(3):42-60. PubMed ID: 4565713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of dextran on the lysis of erythrocytes in nocturnal paroxysmal hemoglobinuria. Studies in vivo and in vitro].
    Tejero Lamarca J; Yangüela Terroba J; Martínez Santos P; Llorente Pérez L
    Sangre (Barc); 1972; 17(3):378-85. PubMed ID: 5081391
    [No Abstract]   [Full Text] [Related]  

  • 18. THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Apr; 44(4):518-34. PubMed ID: 14278168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Targeting therapy strategy for paroxysmal nocturnal hemoglobinuria].
    Feng XY; Ge ML; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):638-41. PubMed ID: 22338165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of preparation Fluidex (Dextran 40,000) on hemolysis and post-transfusion reactions in nocturnal paroxysmal hemoglobinuria].
    Struzik T; Kowalczyk M; Frendo J
    Pol Tyg Lek; 1969 Jul; 24(27):1064-7. PubMed ID: 5805887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.